Testing glucose tolerance right after childbirth
Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard
MemorialCare Health System · NCT04199676
This study is trying to see if testing blood sugar right after childbirth can help women with gestational diabetes get better care and catch any ongoing issues sooner than the usual test done six weeks later.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | MemorialCare Health System (other) |
| Locations | 1 site (Long Beach, California) |
| Trial ID | NCT04199676 on ClinicalTrials.gov |
What this trial studies
This study compares the accuracy of a two-hour glucose tolerance test conducted during postpartum hospitalization with the standard glucose tolerance test performed six weeks after delivery. It aims to determine if testing immediately postpartum can improve compliance rates among women diagnosed with gestational diabetes. The study will capture data on women with gestational diabetes to assess the effectiveness of immediate testing in identifying those with persistent glucose intolerance. By addressing low compliance rates, the study seeks to enhance early diagnosis and treatment opportunities for women at risk of developing type 2 diabetes.
Who should consider this trial
Good fit: Ideal candidates for this study are women who are pregnant or have recently given birth (postpartum day 0 or 1) and have been diagnosed with gestational diabetes.
Not a fit: Patients who are medically excluded from completing glucose tolerance testing or those who have received steroid treatment within 10 days prior to enrollment may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier identification and management of glucose intolerance in postpartum women, reducing the risk of developing type 2 diabetes.
How similar studies have performed: While the approach of immediate postpartum glucose testing is innovative, similar studies have not been widely reported, indicating this may be a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant or recently postpartum (postpartum day 0 or 1) * ≥ 18 years of age * Gestational age ≥34 weeks * A1 or A2 gestational diabetes Exclusion Criteria: * Medical exclusion from completing glucose tolerance testing * Steroid administration within 10 days prior to enrollment * Chronic steroid use
Where this trial is running
Long Beach, California
- Long Beach Memorial Medical Center/Miller Children's and Women's Hospital — Long Beach, California, United States (RECRUITING)
Study contacts
- Principal investigator: Alice Sherman-Brown, MD — Magella Medical Group
- Study coordinator: Alice Sherman-Bron, MD
- Email: alicebrown092@gmail.com
- Phone: (562) 997-8510
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gestational Diabetes